CIK 0001520262 · Large accelerated filer
Alkermes plc.
Sign in to watch- Ticker
- ALKS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981007018
- Phone
- 00-353-1-772-8000
- Business address
- CONNAUGHT HOUSE, 1 BURLINGTON ROAD, DUBLIN 4, Ireland, 00000
- Former names
- ANTLER SCIENCE TWO PLC, Antler Science Two Ltd
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,070,874
- in 5 filings, $1.1M under 10b5-1 plans
Net −$1,070,874. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-05-31 | Alva Emily Peterson Director | Grant or award · Non Qualified Stock Option (Right to Buy) | +17,492 | 17,492 | ||
| 2024-04-11 | Lurker Nancy Director | Grant or award · Restricted Stock Unit Award | +2,323 | 2,323 | ||
| 2024-04-11 | Lurker Nancy Director | Grant or award · Non Qualified Stock Option (Right to Buy) | +4,833 | 4,833 | ||
| 2024-04-11 | Lurker Nancy Director | Grant or award · Restricted Stock Unit Award | +11,255 | 11,255 | ||
| 2024-04-11 | Lurker Nancy Director | Grant or award · Non Qualified Stock Option (Right to Buy) | +22,103 | 22,103 | ||
| 2024-03-18 | Nichols Christian Todd SVP, Chief Commercial Officer | Sale 10b5-1 | −10,417 | $28.10 | $293K | 65,911 |
| 2024-02-27 | Parisi Samuel Joseph VP, Finance (Interim PAO) | Sale | −2,559 | $29.65 | $76K | 7,717 |
| 2024-02-26 | Nichols Christian Todd SVP, Chief Commercial Officer | Grant or award · Employee Stock Option (Right to Buy) | +87,602 | 87,602 | ||
| 2024-02-26 | Nichols Christian Todd SVP, Chief Commercial Officer | Grant or award · Restricted Stock Unit Award | +21,638 | 21,638 | ||
| 2024-02-26 | Parisi Samuel Joseph VP, Finance (Interim PAO) | Grant or award · Employee Stock Option (Right to Buy) | +20,890 | 20,890 | ||
| 2024-02-26 | Parisi Samuel Joseph VP, Finance (Interim PAO) | Grant or award · Restricted Stock Unit Award | +10,986 | 10,986 | ||
| 2024-02-26 | Brown Iain Michael SVP, Chief Financial Officer | Grant or award · Employee Stock Option (Right to Buy) | +90,971 | 90,971 | ||
| 2024-02-26 | Brown Iain Michael SVP, Chief Financial Officer | Grant or award · Restricted Stock Unit Award | +22,471 | 22,471 | ||
| 2024-02-26 | Gaffin David Joseph EVP, CLO, Alkermes, Inc. | Grant or award · Employee Stock Option (Right to Buy) | +111,186 | 111,186 | ||
| 2024-02-26 | Gaffin David Joseph EVP, CLO, Alkermes, Inc. | Grant or award · Restricted Stock Unit Award | +27,464 | 27,464 | ||
| 2024-02-26 | Jackson Blair Curtis EVP, Chief Operating Officer | Grant or award · Employee Stock Option (Right to Buy) | +134,771 | 134,771 | ||
| 2024-02-26 | Jackson Blair Curtis EVP, Chief Operating Officer | Grant or award · Restricted Stock Unit Award | +33,289 | 33,289 | ||
| 2024-02-26 | Hopkinson Craig C. EVP R&D, Chief Medical Officer | Grant or award · Employee Stock Option (Right to Buy) | +111,186 | 111,186 | ||
| 2024-02-26 | Hopkinson Craig C. EVP R&D, Chief Medical Officer | Grant or award · Restricted Stock Unit Award | +27,464 | 27,464 | ||
| 2024-02-26 | POPS RICHARD F Director and CEO, Alkermes plc | Grant or award · Employee Stock Option (Right to Buy) | +274,328 | 274,328 |
Page 24 of 41 · 804 trades